Procedural Advantages of a Novel Drug-Eluting Coronary Stent
Not Applicable
Completed
- Conditions
- Coronary Artery Disease
- Registration Number
- NCT02881216
- Lead Sponsor
- University Hospital Heidelberg
- Brief Summary
This study sought to compare procedural performance of a new coronary stent generation, that is already available in Germany, with hitherto established current drug-eluting stents.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 814
Inclusion Criteria
- CAD for PCI, consecutive patients
Exclusion Criteria
- Age under 18
- Bare Metal Stents or Scaffolds
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method In-hospital major cardiac adverse events One week post-procedure In-hospital major cardiac adverse events were collected up to one week after procedure throughout the in-patients stay
- Secondary Outcome Measures
Name Time Method